ID   LB265-MEL
AC   CVCL_VV11
DR   Wikidata; Q95981489
RX   PubMed=8752841;
RX   PubMed=11751535;
CC   From: Ludwig Institute for Cancer Research, Brussels Branch; Brussels; Belgium.
CC   HLA typing: A*02,03; B*07,62; C*w07,w09 (PubMed=8752841).
CC   Derived from site: Metastatic; Cervical lymph node; UBERON=UBERON_0002429.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   72Y
CA   Cancer cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 4
//
RX   PubMed=8752841; DOI=10.1111/1523-1747.ep12298177;
RA   Zarour H.M., De Smet C., Lehmann F., Marchand M., Lethe B., Romero P.,
RA   Boon T., Renauld J.-C.;
RT   "The majority of autologous cytolytic T-lymphocyte clones derived from
RT   peripheral blood lymphocytes of a melanoma patient recognize an
RT   antigenic peptide derived from gene Pmel17/gp100.";
RL   J. Invest. Dermatol. 107:63-67(1996).
//
RX   PubMed=11751535; DOI=10.1093/clinchem/48.1.25;
RA   Zammatteo N., Lockman L., Brasseur F., De Plaen E., Lurquin C.,
RA   Lobert P.-E., Hamels S., Boon T., Remacle J.;
RT   "DNA microarray to monitor the expression of MAGE-A genes.";
RL   Clin. Chem. 48:25-34(2002).
//